| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| FLUPHENAZINE (is an active metabolite)
| FLUPHENAZINE | NERVOUS SYSTEM | ORAL INJECTION | HT 16.4 HOUR | D(1) DOPAMINE RECEPTOR D(2) DOPAMINE RECEPTOR | D(2) dopamine receptor UNIPROT P14416 DRD2 more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| FLUPHENAZINE DECANOATE (has an active metabolite)
| FLUPHENAZINE DECANOATE | NERVOUS SYSTEM | INJECTION | D2 DOPAMINE RECEPTOR | D(2) dopamine receptor UNIPROT P14416 DRD2 -- D(2) dopamine receptor UNIPROT P14416 DRD2 more at DrugCentral | EMA | ||||
